Leading Los Angeles Cancer Center Enhances Radiotherapy Capabilities with LinaTech's Second 102 Leaf DMLC

May 14, 2011

Valley Cancer Institute, a leading cancer clinic in Los Angeles, has acquired a second 102 Leaf DMLC from LinaTech to deliver advanced radiotherapy treatments. Since the initial use of the existing 102 Leaf DMLC, many patients have been treated with fast and precise radiotherapy at Valley Cancer Institute in Culver City/Los Angeles.

The lead medical physicist at Valley Cancer Institute, James Gonzalez, stated, "We have successfully treated hundreds of patients with essentially zero downtime."

With the acquisition of a second 102 Leaf DMLC, Valley Cancer Institute is expected to see an increase in the number of patients they serve. The institute currently uses equipment and software from a variety of suppliers but is moving towards LinaTech as their main supplier for specific RT machines and software.

By investing in LinaTech's advanced radiotherapy solutions, Valley Cancer Institute is ensuring that they can continue to deliver the best possible care to their patients. With LinaTech's cutting-edge technology and commitment to improving cancer treatment outcomes, the clinic is poised to remain a leading player in the field of cancer treatment in the Los Angeles area and beyond.

To learn more, please contact us.